News
CROMSOURCE Regulatory Newsletter January – March 2023
CROMSOURCE announces publication of its latest Regulatory Newsletter summarising important updates from January – March 2023.
Dialco Medical Inc. Engages CROMSOURCE as CRO Partner for DIMI IDE Trial
Dialco’s selection of CROMSOURCE as their partner for their DIMI IDE trial reinforces CROMSOURCE’s position as a global leader in conducting medical device trials. “The CROMSOURCE team is excited to partner with such a recognized global leader as Dialco and their...
CROMSOURCE Announces Appointment of Kris O’Brien as Global Head of TalentSource Life Sciences
CROMSOURCE announced today the appointment of Kris O’Brien as Global Head of TalentSource Life Sciences, CROMSOURCE’s flexible resourcing division of the company which is dedicated to working with clients on finding the best resource solutions to meet their needs. ...
CROMSOURCE Consolidates Strategic Site Support Service
CROMSOURCE announced today the expansion of its Strategic Site Support Service that can be provided to sites participating in clinical research studies managed by CROMSOURCE on behalf of companies in the pharmaceutical, biotechnology, and medical device industries, or...
CROMSOURCE Announces Launch of COVID-19 Clinical Trial
CROMSOURCE has announced that it has initiated its first COVID-19 trial on behalf of a European pharmaceutical company. This trial is expected to be performed in Italy, though additional studies are planned by CROMSOURCE for other countries in Europe as well as the...
CROMSOURCE announces a significant milestone in digital management of its projects in cooperation with TECHORIZON
CROMSOURCE announced today the achievement of a significant milestone in the digital management of clinical research projects for their clients. In February 2020 CROMSOURCE initiated the 1000th trial to be managed within the advanced TheClinical digital environment....
CROMSOURCE Consolidates its Hybrid Services Model
CROMSOURCE, an international contract research organization (CRO), has announced consolidation of its Hybrid Services Model. Due to client demand, CROMSOURCE has further refined its Hybrid Services to be able to provide its pharmaceutical, medical device, and...
CROMSOURCE Continues US Growth with New Office in Research Triangle Park
CROMSOURCE, an international contract research organization (CRO) has just opened a newly expanded office in Cary, NC. Download this press release.
Penta and CROMSOURCE Announce their Partnership to Improve Paediatric Drug Development
Penta ID Innovation, a recently established SMO stemmed from the Penta Global Paediatric Research Network, and CROMSOURCE, an international contract research organization (CRO) providing a comprehensive portfolio of services to the pharmaceutical, biotechnology, and...
CROMSOURCE Appoints Director of Regulatory Services and Expands Regulatory Operations
CROMSOURCE announces publication of its latest Regulatory Newsletter summarising important updates from October to December 2018 Download here: CROMSOURCE Regulatory Newsletter October – December 2018
CROMSOURCE Unveils New TalentSource Department Logo
CROMSOURCE announced the formalisation of an expanded Flexible Resourcing Solutions offering, delivered by the TalentSource Department, with a new logo. The new branding uses the design elements of the existing CROMSOURCE brand, while maintaining the TalentSource name...
CROMSOURCE Offers Clients One Trial One Price™ Guarantee
CROMSOURCE announced a service offering and guarantee for their clients – One Trial One PriceTM. This service offering was created based on feedback from existing and prospective clients frustrated with the trend of post-award change orders resulting from an...
CROMSOURCE Celebrates its 20th Anniversary
CROMSOURCE marks its twentieth anniversary of providing high quality clinical research services and exceptional customer support to our global pharmaceutical, biotechnology, and medical device clients.
Events
Publications
Follow TalentSource on LinkedIn to see our company news, our job opportunities and connect with our employees.